DNAprint Genomics (DNAG)

[frogdreaming]

DougS - You are making too many assumptions.

DNAP does not have any drugs yet. If they have anything worth stealing at this time it is the genomic IP.

If a pharma has the technical expertise to recognize the 'value' of DNAP's technology then they have the capability to duplicate it given the nature of the patent process.

The instructions for patent disclosure require that the application be written such that a person 'practiced in the art' could duplicate and use the discovery presented in the application.

With the purchase of a machine equivalent to the 'borrowed' Orchid device and a copy of the patent, anyone adept in the art can duplicate the discovery. Potentially, with enough money and duplicity, inconsequential changes could be made to get around the patent itself.

The fact that no one seems to be chomping at their heels might be more indicative of a lack of interest than a lack of capability.

frog